Responsibility
Our Approach
"Corporate responsibility has become an integral part of our corporate decision-making process. This makes sound business sense, enabling us to benefit from the adoption of sustainable behaviours for the environment and to strengthen our relationships with customers and other business contacts."
Louise Makin, CEO
Our Corporate Responsibility (CR) Committee comprises individuals from across the business, meets quarterly to discuss new trends, set targets and monitors progress. The Committee reports to Rolf Soderstrom, our Chief Financial Officer and the Board member with responsibility for this area of the business.
Reporting criteria
Our CR reporting criteria, listed below, feature widely in peer pharmaceutical company CR disclosures and have been carefully chosen as most relevant to our business.
Our latest Annual Report includes a full summary of all our 2010-11 activities, together with data to help us understand and manage our various community and environmental impacts.
BTG is a member of the FTSE4Good index series, designed to objectively measure the performance of companies that meet globally recognised corporate responsibility standards.
BTG is also a constituent of the Kempen SNS SRI Universe, which indicates that we have passed stringent criteria and can be considered a company that demonstrates a clear strategy towards Corporate Social Responsibility.
Doing the right thing
Our Board of Directors is committed to ensuring that high standards of governance underpin the management of our business affairs.
Our culture
Find out about how we’re building a collaborative spirit, based on mutual respect, where employees have a clear sense of purpose.